The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

The Senate has confirmed Dr Jay Bhattacharya as the new director of the NIH and Dr Marty Makary as the new commissioner of the FDA.

Investigators report findings from an analysis of 7836 robotic-assisted radical cystectomies performed from 2010 to 2021.

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.

Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...

To mitigate the influence of selection bias, investigators matched patients undergoing active surveillance and partial nephrectomy for small renal masses by their risk of dying of noncancer causes.

A patient-reported outcomes trial used the ICIQ-S to compare patient experiences and satisfaction after ureteroscopy with placement of a silicone or polyurethane stent.

Maintaining systolic blood pressure consistently below 130 mmHg could help decrease the risk for new-onset diabetes in the ...

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

Durvalumab plus gemcitabine and cisplatin significantly improved event free survival and overall survival compared with gemcitabine and cisplatin. The Food and Drug Administration (FDA) has ...

There is a high unmet need for effective neoadjuvant treatments for muscle-invasive bladder cancer for patients who cannot tolerate or refuse cisplatin chemotherapy.